MarketBeat on MSN

Aura Biosciences gears up for Bel-Sar filing as pivotal eye cancer trial advances

Key Points Interested in Aura Biosciences, Inc.? Here are five stocks we like better. Aura Biosciences is nearing completion ...
Medical Xpress

New study could improve testing and treatment for rare brain, spinal cord, and eye cancers

A new study has identified hepatitis A virus cellular receptor 1 (HAVCR1) as a biomarker that could make it easier to ...
MarketBeat on MSN

Aura Biosciences highlights Bel-Sar eye cancer strategy, mid-year bladder data

Key Points Interested in Aura Biosciences, Inc.? Here are five stocks we like better. Aura Biosciences says its lead drug bel ...
UC San Diego Today

AI Model Links Tumor Mutations to Treatment Response

A new AI tool discovered by UC San Diego improved prediction of how multiple cancers may respond to treatment ...
Medical Xpress

Eye Diseases: News and Research on Eye Neoplasms

Researchers at the Optics and Photonics Research Center (CePOF) in Brazil and collaborators at the University of Toronto and Princess Margaret Cancer Center in Canada have reported for the first time ...
ascopubs.org

Desmoid Tumors—Biology-Driven Management and Treatment Selection

Tech That Scales: A Practical Framework for Artificial Intelligence–Enabled Cancer Care in Low- and Middle-Income Countries and Underserved US Counties Desmoid tumors (DTs) are rare fibroblastic ...